Armistice Capital »

Regal-beloit Corporation shares owned by Armistice Capital

Quarter-by-quarter ownership of Regal-beloit Corporation (RRX) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Regal-beloit Corporation

Tip: Access up to 7 years of quarterly data

All positions including Regal-beloit Corporation held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regal-beloit Corporation by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.0M 13k 238.19

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Regal-beloit Corporation

BlackRock
FMR
Victory Capital Management
Vanguard Capital Management
Vanguard Portfolio Management
Wellington Management Company
Viking Global Investors
State Street Corporation
Dimensional Fund Advisors
Bank of New York Mellon
Nuveen
Invesco
Nordea Investment Management Ab
Geode Capital Management
Barrow, Hanley, Mewhinney & Strauss

View all funds holding Regal-beloit Corporation